Ginkgo Bioworks Holdings (DNA) Capital Expenditures Growth (1y) (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 451.19 Mn | 307.33 Mn | 16.38 Mn | -101.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.23% |
| Dec 31, 2025 | -99.99% |
| Sep 30, 2025 | 1,282.89% |
| Jun 30, 2025 | -27.57% |
| Mar 31, 2025 | 13.59% |
| Dec 31, 2024 | 63.77% |
| Sep 30, 2024 | 97.89% |
| Jun 30, 2024 | -143.43% |
| Mar 31, 2024 | -65.49% |
| Dec 31, 2023 | -9.94% |
| Sep 30, 2023 | -415.64% |
| Jun 30, 2023 | 414.37% |
| Mar 31, 2023 | 978.89% |
| Dec 31, 2022 | 183.10% |
| Sep 30, 2022 | 76.19% |
| Jun 30, 2022 | -89.05% |
| Mar 31, 2022 | -110.08% |
| Dec 31, 2021 | -362.03% |